Sort   by:  
 Page size 
UnknownCombination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients.
Not available
S-EPMC8837058 | biostudies-literature
UnknownHemophilia A: different phenotypes may be explained by multiple and variable effects of the causative mutation in the F8 gene.
Not available
S-EPMC5792263 | biostudies-literature
Unknownvon Willebrand factor regulation of blood vessel formation.
Not available
S-EPMC6182264 | biostudies-literature
Unknownvon Willebrand disease and von Willebrand factor.
Not available
S-EPMC9094051 | biostudies-literature
Unknownvon Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
Not available
S-EPMC3856360 | biostudies-literature
UnknownThe Arrival of Gene Therapy for Patients with Hemophilia A.
Not available
S-EPMC9499514 | biostudies-literature
UnknownExposure-Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD.
Not available
S-EPMC11211018 | biostudies-literature
UnknownA literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors.
Not available
S-EPMC11909758 | biostudies-literature
UnknownSurgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors.
Not available
S-EPMC10786707 | biostudies-literature
UnknownNatural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain.
Not available
S-EPMC12711066 | biostudies-literature
Sort   by:  
 Page size